These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111 [TBL] [Abstract][Full Text] [Related]
24. ADP-induced inhibition of von Willebrand factor-mediated platelet agglutination. Grant RA; Zucker MB; McPherson J Am J Physiol; 1976 May; 230(5):1406-10. PubMed ID: 818909 [TBL] [Abstract][Full Text] [Related]
25. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam. Romstedt K; Huzoor-Akbar Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062 [TBL] [Abstract][Full Text] [Related]
26. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen. Ts'ao C Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732 [TBL] [Abstract][Full Text] [Related]
27. Collagen-induced platelet aggregation: the role of adenine nucleotides and the release reaction. Kattlove H; Gomez MH Thromb Diath Haemorrh; 1975 Dec; 34(3):795-805. PubMed ID: 813326 [TBL] [Abstract][Full Text] [Related]
28. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
29. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062 [TBL] [Abstract][Full Text] [Related]
30. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515 [TBL] [Abstract][Full Text] [Related]
31. Effects of trifluoperazine on platelet activation. Ardlie NG; Boatwright C; Garrett J; McGuiness JA Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211 [TBL] [Abstract][Full Text] [Related]
32. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets. Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979 [TBL] [Abstract][Full Text] [Related]
33. Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation. Molica F; Morel S; Meens MJ; Denis JF; Bradfield PF; Penuela S; Zufferey A; Monyer H; Imhof BA; Chanson M; Laird DW; Fontana P; Kwak BR Thromb Haemost; 2015 Aug; 114(2):325-36. PubMed ID: 25947940 [TBL] [Abstract][Full Text] [Related]
34. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors. Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464 [TBL] [Abstract][Full Text] [Related]
35. Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial. Spiel AO; Bartko J; Schwameis M; Firbas C; Siller-Matula J; Schuetz M; Weigl M; Jilma B Thromb Haemost; 2011 Apr; 105(4):655-62. PubMed ID: 21301783 [TBL] [Abstract][Full Text] [Related]
36. Interrelation of platelet aggregation, release reaction and thromboxane A2 production. Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682 [TBL] [Abstract][Full Text] [Related]
37. Cycles of agglutination-disagglutination induced by ristocetin in thrombasthenic platelets. Chediak J; Telfer MC; Vander Laan B; Maxey B; Cohen I Br J Haematol; 1979 Sep; 43(1):113-26. PubMed ID: 574390 [TBL] [Abstract][Full Text] [Related]
38. Platelet aggregation responses vary over a period of time in healthy controls. Refaai MA; Frenkel E; Sarode R Platelets; 2010; 21(6):460-3. PubMed ID: 20536288 [TBL] [Abstract][Full Text] [Related]
39. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids. Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366 [TBL] [Abstract][Full Text] [Related]
40. [Quantitative method of measuring platelet ATP released in vitro in the presence of various aggregating agents]. Jung G; Hénon P Pathol Biol (Paris); 1984 Sep; 32(7):772-8. PubMed ID: 6436777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]